 |
|
|
The technologies and products of the five Israeli companies
participating in the MarketReach America Life Sciences
2004 represent originality, dedication, and innovation.
|
Andante Medical Devices
|
Improving the rehabilitation process
Andante is the developer of Smart Step, an
affordable, miniature, mobile monitoring and biofeedback
system for lower limb rehabilitation. Smart Step
is designed for use by patients undergoing rehabilitation
following injuries to the lower extremities, joint
replacement, and soft tissue injuries; lower limb
amputation; and neurological deficits such as
cerebral palsy and hemiparesis. The system provides
an instantaneous and accurate assessment of the
patient's weight-bearing performance and supports
biofeedback gait training. It enables therapists
to determine therapy goals, quantify patient performance,
and evaluate the benefits of the treatment.
CEO and founder: Arik Avni
|
|
Read more
about Andante
|
| Chiasma |
Oral delivery of large molecule drugs
Chiasma Ltd. develops the proprietary InBitWin
Cargo Delivery (ICD) platform technology — an
innovative method employing a simple biological
solution for oral delivery of large molecule drugs
into the bloodstream. Chiasma's penetrating module
achieves nearly 30% bioavailability within 10
minutes. The technology enables accurate delivery
of precise quantities of therapeutic macromolecules.
While the company's technology has been specifically
developed for penetration of the epithelial layer
in the gastrointestinal tract, it can also be
applied to other delivery routes including nasal,
transmucosal, and inhalation.
CEO and founder: Guy Yachin
|
|
Read more
about Chiasma
|
ETView
|
Airway management in acute respiratory failure
ETView Ltd. has
developed an innovative approach to airway management
in acute respiratory failure, emergency medicine,
and anesthesia. The company's proprietary endotracheal
tube (ETT) with a built-in camera enables a clear
view of the upper airway during intubation via
a portable monitor to permit safe and easy intubation.
The ETView ETT offers continuous monitoring of
the ETT position inside the trachea during the
entire process and subsequent transport and treatment
for more, effective ventilation during the intubation
process, thereby decreasing the risk to the patient.
The device eliminates the need for laryngoscopes
or bronchoscopes.
CEO: Ofer Fridman
|
|
Read more
about ETView
|
MGVS
|
Cell therapy for vascular disorders
Multi Gene Vascular Systems (MGVS) Ltd. has developed innovative cell therapy products to address
a number of vascular-related disorders. The company's
therapies utilize multiple genes in conjunction
with the patient's own (autologous) endothelial
and smooth muscle cells. MGVS currently has three
products in the pipeline based on its platform
technology: angiogenesis therapy for patients
with arterial obstructive diseases, bio-engineered
grafts for use with peripheral vascular and end-stage
renal diseases, and angiogenesis and liver regeneration
therapy for patients with cirrhosis.
Managing director and co-founder: Dr. Moshe
Flugelman
|
|
Read more
about MGVS
|
SLP Ltd.
|
Smart sensors for sleep disorders
SLP Ltd. has
developed the "smart sensor" platform for at-home testing of sleep
disorders. SLP's smart sensors
are the only products that provide validated clinical
information about sleep disorders in real time.
The company has developed a number of sensor-based
products: SleepStrip®, screening for
sleep apnea; BiteStrip™,
testing for sleep bruxism; and KickStrip™, testing for periodic limb movement disorder (PLMD).
All SLP sensors are easy to use by patients in the comfort of their own home, disposable (single use), and low cost.
CEO: Noam Hadas |
|
Read more
about SLP
|
|
|
